
Mankind Pharma Ltd spurts 2.92%, gains for five straight sessions
Mankind Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2653.7, up 2.92% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.37% on the day, quoting at 25055.85. The Sensex is at 82161.62, down 0.41%. Mankind Pharma Ltd has added around 11.97% in last one month.
Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has added around 1.97% in last one month and is currently quoting at 22225.9, up 1.11% on the day. The volume in the stock stood at 10.75 lakh shares today, compared to the daily average of 7.73 lakh shares in last one month.
The benchmark July futures contract for the stock is quoting at Rs 2660.3, up 3.07% on the day. Mankind Pharma Ltd is up 23.51% in last one year as compared to a 1.91% gain in NIFTY and a 7.81% gain in the Nifty Pharma index.
The PE of the stock is 56.47 based on TTM earnings ending March 25.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
28 minutes ago
- Economic Times
Tata Technologies Q1 Results: Cons PAT grows 5% YoY to Rs 170 crore; revenue down 2%
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
&w=3840&q=100)

Business Standard
29 minutes ago
- Business Standard
HCLTech Q1 FY26: Net profit down 9.1% YoY to ₹3,843 cr, dividend declared
HCLTech on Monday reported a 9.1 per cent year-on-year (Y-o-Y) decline in net profit to ₹3,843 crore for the quarter ended June 2025 (Q1 FY26), compared to ₹4,257 crore in the same period last year, according to a BSE filing by the company. However, revenue from operations increased 8 per cent to Rs 30,349 crore in Q1FY26 Y-o-Y from Rs 28,057 crore in Q1FY25. The board of directors also approved an interim dividend of ₹12 per share. Shares of HCLTech closed at ₹1,619.95 apiece on the BSE on Monday.
&w=3840&q=100)

Business Standard
30 minutes ago
- Business Standard
Andhra draws roadmap to create global space hub, eyes Rs 25,000 cr by 2035
Two space cities planned in Lepakshi and Tirupati, spanning 33,000 acres, to attract global investments and align with Centre's Rs 1.5 trillion space sector roadmap Shine Jacob Chennai Listen to This Article Giving a much-needed impetus to India's ambition of becoming a $44 billion space economy by 2033, the Andhra Pradesh government on Saturday cleared a dedicated space policy, which aims to attract investments worth around ₹25,000 crore over the next ten years, transforming the state into a global space manufacturing hub, said a top government source. This will be done through the development of two integrated space cities in Lepakshi and Tirupati, spread across approximately 33,000 acres. The N Chandrababu Naidu government said it is working to build this comprehensive space ecosystem in alignment with the central government's plans